Reduced Thrombus Formation by Hyaluronic Acid Coating of Endovascular Devices

ABSTRACTBiocompatible stent coatings may alleviate problems of increased (sub)acute thrombosis after stent implantation. Hyaluronic acid (HA), a ubiquitous, nonsulfated glycosaminoglycan, inhibits platelet adhesion and aggregation and prolongs bleeding when administered systemically. However, the ef...

Full description

Saved in:
Bibliographic Details
Published inArteriosclerosis, thrombosis, and vascular biology Vol. 20; no. 4; pp. 1168 - 1172
Main Authors Verheye, Stefan, Markou, Christos P, Salame, Mahomed Y, Wan, Barbara, King, Spencer B, Robinson, Keith A, Chronos, Nicolas A. F, Hanson, Stephen R
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Heart Association, Inc 01.04.2000
Hagerstown, MD Lippincott
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACTBiocompatible stent coatings may alleviate problems of increased (sub)acute thrombosis after stent implantation. Hyaluronic acid (HA), a ubiquitous, nonsulfated glycosaminoglycan, inhibits platelet adhesion and aggregation and prolongs bleeding when administered systemically. However, the effects of immobilized HA for reducing stent platelet deposition in vivo are unknown. We therefore quantified the antithrombotic effects of coating stainless steel stents and tubes with HA using an established baboon thrombosis model under physiologically relevant blood flow conditions. HA-coated and uncoated (control) stents (3.5 mm in diameter, n=32) and stainless steel tubes (4.0 mm in diameter, n=18) were deployed into exteriorized arteriovenous shunts of conscious, nonanticoagulated baboons. Accumulation of In-radiolabeled platelets was quantified by continuous gamma-camera imaging during a 2-hour blood exposure period. HA coating resulted in a significant reduction in platelet deposition in long (4 cm) tubes (0.24±0.15×10 versus 6.12±0.49×10 platelets;P <0.03), short (2 cm) stainless steel tubes (0.18±0.06×10 versus 3.03±0.56×10 platelets;P <0.008), and stents (0.82±0.20×10 versus 1.83±0.23×10 platelets;P <0.02) compared with uncoated control devices. Thus, HA coating reduces platelet thrombus formation on stainless steel stents and tubes in primate thrombosis models. These results indicate that immobilized HA may represent an attractive strategy for improving the thromboresistance of endovascular devices.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1079-5642
1524-4636
DOI:10.1161/01.ATV.20.4.1168